Category: TB

US Supreme Court Adopts International Exhaustion For Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices

Source : By Frederick M The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v. Lexmark International, No. 15-1189. The near-unanimous decision...

/ 1 June 2017

Access to medicines amendment of the WTO TRIPS Agreement– hype or hope?

By: Ellen ‘t Hoen, Global Health Unit Department of Health Sciences, UMCG Groningen, e.f.m.t.hoen@umcg.nl On 30 January the World Trade Organization (WTO) announced the first ever amendment to the TRIPS Agreement under the headline WTO members welcome entry into force of...

/ 5 April 2017

M-Coalition launch a new guide: Key Population Engagement in Global Fund Country Dialogue CCMs and the 2017-­‐2019 funding cycle

Source : M-Colaition This resource guide is designed to assist civil society organizations in understanding how to access funding from the Global Fund (GF) and effectively engage in country dialogue through all the key stages. In 2014, the Global Fund’s...

/ 21 March 2017

Amendment of the TRIPS Agreement

WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally built into the TRIPS Agreement after...

/ 23 January 2017

Global Fund Notifies Countries on 2017-2019 Allocations

For the 2017-2019 allocation period, the Global Fund adopted a refined allocation methodology to deliver the aims of its 2017-2022 strategy and to increase the impact of country programs that prevent, treat and care for people affected by HIV, TB...

/ 21 December 2016

The Global Fund has a new Sustainability, Transition, and Co-financing Policy

Which means that for the next allocation period, the Global Fund will proactively support sustainability and transition planning, especially for upper middle income countries (UMICs) and low middle income countries (LMICs) with low or moderate disease burdens. Download the new...

/ 6 December 2016

Civil Society Calls on WHO to Include Report from UN’s High Level Panel on Medicines on WHO Board Agenda

Dear Director General Dr. Margaret Chan Request to include discussion of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines at the next WHO Board meeting As members of the Make Medicines Affordable campaign, and other Civil...

/ 28 February 2016

Morocco: Creation of a collective for t the right to health in the framework of the negotiations of the EU ALECA

At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the "comprehensive and thorough free trade agreement" (FTAA), Moroccan civil society unites to bell Alarm about ALECA's danger of access to generics...

/ 12 January 2016

Launch of the MENA Regional Platform on Global Fund and Civil Society

The Global Fund in the MENA region The Global Fund against AIDS, Tuberculosis and Malaria (GFATM) is the largest financing institution that supports government and civil society in their response to HIV, TB and malaria in the Middle East and...

/ 12 January 2016